Search

everythinglearnresearchcommunity

for

Search:↓

Further testing of paclitaxel poliglumex for this cancer treatment is not justified.

Blocking certain proteins can significantly regrow hair in severe alopecia areata.

Medicaid coverage for alopecia areata treatments is inconsistent and often limited.

Most patients experienced hirsutism again after stopping hormone treatment, indicating long-term treatment is needed to maintain results.

Checkpoint inhibitor therapy can cause skin issues, from mild rashes to severe reactions.

Mesalazine showed limited effectiveness in treating children with severe alopecia areata.

SLE patients need careful diagnosis to distinguish infections from disease flares for proper treatment.

Probiotics significantly reduce the severity of atopic dermatitis.

5-alpha reductase inhibitors don't increase breast cancer or benign breast disorder risk in women.

Adalimumab may cause severe hair loss in some patients.

ALA-photodynamic therapy helps reduce acne by causing acne cell death and lowering certain skin protein levels.

Early diagnosis and treatment of SLE are crucial to prevent severe complications.

Tofacitinib treatment is used for teenagers with alopecia areata.

Combining Ficlatuzumab and Gefitinib can cause severe hair loss.

The combination therapy is safe and more effective for treating pediatric facial and cervical vitiligo.

A topical treatment safely and effectively reduced acne by causing targeted cell death in sebaceous glands without side effects.

Tofacitinib might be used to treat hair loss.

Methotrexate reduced the need for steroids in asthma patients without worsening their condition.

Isotretinoin effectively improved severe pityriasis rubra pilaris with complications.

Methotrexate for rheumatoid arthritis often causes side effects like diarrhea, fatigue, and hair loss, especially at higher doses.

Retinol significantly reduces neck wrinkles.

Researchers developed a method to measure different forms of a drug that could help treat prostate issues and hair loss, and found how these forms behave in animals.

Topical Ruxolitinib may safely treat severe hair loss.

A rash from semaglutide may be due to propylene glycol, not the drug itself.

Ritlecitinib successfully treated a child's alopecia universalis after baricitinib failed.

Bendamustine combined with rituximab is an effective and well-tolerated treatment for certain types of lymphoma.

Tofacitinib was effective for severe, treatment-resistant hair loss without side effects.

Tralokinumab for atopic dermatitis may cause eye issues and skin reactions, needing careful monitoring.

Selumetinib significantly reduced tumor size and improved vision in a child with neurofibromatosis type 1.

LDL apheresis lowers inflammation and cardiovascular risk by reducing CRP levels long-term.